|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.799 USD | -0.39% |
|
-7.03% | -43.33% |
| Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
| Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Effective on August 1, 2022, the board of directors of Lucid Diagnostics Inc. appointed Debra J. White as a Class C director of the Company. Ms. White has been named to the nominating and corporate governance and audit committees of the Board. Ms. White replaces Aster Angagaw, who resigned as a director effective on July 30, 2022.
Ms. Angagaw's resignation was not due to a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
| 1st Jan change | Capi. | |
|---|---|---|
| -43.33% | 38.7M | |
| +71.87% | 12.28B | |
| -19.76% | 8.08B | |
| +15.96% | 7.23B | |
| -6.42% | 5.29B | |
| +4.54% | 4.93B | |
| +18.62% | 4.19B | |
| -21.30% | 4.13B | |
| -40.48% | 2.24B | |
| -3.47% | 2B |
LUCID DIAGNOSTICS INC. 
